Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy

Int J Mol Sci. 2021 Sep 28;22(19):10471. doi: 10.3390/ijms221910471.

Abstract

Liver disease is a global health issue that has caused an economic burden worldwide. Organ transplantation is the only effective therapy for end-stage liver disease; however, it has been hampered by a shortage of donors. Human pluripotent stem cells (hPSCs) have been widely used for studying liver biology and pathology as well as facilitating the development of alternative therapies. hPSCs can differentiate into multiple types of cells, which enables the generation of various models that can be applied to investigate and recapitulate a range of biological activities in vitro. Here, we summarize the recent development of hPSC-derived hepatocytes and their applications in disease modeling, cell therapy, and drug discovery. We also discuss the advantages and limitations of these applications and critical challenges for further development.

Keywords: cell therapy; disease models; hepatocyte-like cells; human pluripotent stem cells; liver disease; liver organoids.

Publication types

  • Review

MeSH terms

  • Drug Discovery*
  • Hepatocytes / metabolism*
  • Humans
  • Liver Diseases* / metabolism
  • Liver Diseases* / therapy
  • Organoids / metabolism*
  • Pluripotent Stem Cells / metabolism*